New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers.
Saved in:
| Title: | New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers. |
|---|---|
| Authors: | Battaglia G; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy., Lazzarotto D; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy., Tanasi I; Hematology Unit, Department of Engineering for Innovation Medicine, Azienda Ospedaliera Universitaria Integrata di Verona, 37126 Verona, Italy., Gurrieri C; Hematology Unit, Azienda Ospedale-Università and University of Padova, 35128 Padua, Italy., Forlani L; Hematology Unit, Azienda Ospedale-Università and University of Padova, 35128 Padua, Italy., Mauro E; Hematology Section, Dipartimento di Medicina Specialistica, Ca' Foncello Hospital, 31100 Treviso, Italy., Capraro F; Hematology Unit, Azienda Ulss3 Serenissima, Ospedale dell'Angelo, 30174 Venice, Italy., Ciotti G; Department of Oncology, UOC Oncohematology, Istituto Oncologico Veneto (IOV) IRCCS, 35128 Padova, Italy., De Bellis E; Hematology Unit, Azienda Sanitaria Universitaria Giuliano Isontina, 34148 Trieste, Italy.; Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy., Callegari C; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy., Tosoni L; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy., Fanin M; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy., Morelli GL; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy., Simio C; Hematology Unit, Department of Engineering for Innovation Medicine, Azienda Ospedaliera Universitaria Integrata di Verona, 37126 Verona, Italy., Skert C; Hematology Unit, Azienda Ulss3 Serenissima, Ospedale dell'Angelo, 30174 Venice, Italy., Gottardi M; Department of Oncology, UOC Oncohematology, Istituto Oncologico Veneto (IOV) IRCCS, 35128 Padova, Italy., Zaja F; Hematology Unit, Azienda Sanitaria Universitaria Giuliano Isontina, 34148 Trieste, Italy., Toffoletti E; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy.; Department of Medicine, University of Udine, 33100 Udine, Italy., Damiani D; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy.; Department of Medicine, University of Udine, 33100 Udine, Italy., Fanin R; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy.; Department of Medicine, University of Udine, 33100 Udine, Italy., Tiribelli M; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy.; Department of Medicine, University of Udine, 33100 Udine, Italy. |
| Source: | Journal of clinical medicine [J Clin Med] 2025 Jan 22; Vol. 14 (3). Date of Electronic Publication: 2025 Jan 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2077-0383 |
|---|---|
| DOI: | 10.3390/jcm14030700 |
